The allergy diagnostics market is projected to reach USD 8.2 billion by 2026 from USD 4.8 billion in 2021, at a CAGR of 11.1% from 2021 to 2026. Allergy testing aids in determining the substances that are causing allergy symptoms in a patient. Tests include a skin test, intradermal test, challenge test, blood test and patch test. Allergists commonly conduct challenge tests; these include food challenge, inhalation challenge, drug challenge, and physical challenge. Allergy tests such as in vitro & in vivo tests are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases. Factors such as the high incidence of allergic diseases and associated heavy economical burden, rising environmental pollution levels, increasing funds by organizations in allergy diagnostics, and the increasing access to healthcare insurance are supporting the growth of this market. The Asia Pacific market is estimated to be the fastest-growing regional market, mainly due to developing healthcare infrastructure, lifestyle changes and climatic conditions, increase in ozone and industrial pollution levels, and the rising demand for quality medical care.
The allergy diagnostics market is competitive in nature, with only a few players dominating the overall market. The major players operating in this market are Thermo Fisher Scientific Inc., (US), Siemens Healthineers (Germany), Danaher (US), Omega Diagnostics Group PLC (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), NEOGEN Corporation (US), Eurofins Scientific (Luxembourg), Minaris Medical America, Inc. (US), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), and Erba Group (UK).
To know about the assumptions considered for the study download the pdf brochure
Thermo Fishers Scientific Inc. (US)
Thermo Fisher Scientific Inc., a US-based company, is the leading player in the allergy diagnostics market, accounting for a share of 14.6% in 2020. The company’s strong position in the market can be primarily attributed to its product portfolio. Phadia instruments offered by the company are extensively used by laboratories and other healthcare settings for allergy testing. Besides, the company also has a strong geographic presence, which is the main factor for the company’s strong customer base. The company serves more than 400,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial quality and process control settings.
Danaher held the second-largest share of 10.2% of the allergy diagnostics market in 2020. Danaher operates through its subsidiary Beckman Colter in the allergy diagnostics market under the business subsegment of Core Lab Diagnostics. The Core Lab business caters end users with biomedical testing instruments, systems, and related consumables to evaluate and analyze body fluids, cells, and other substances. The information generated is used to diagnose diseases, monitor and guide treatment & therapy, assist in managing chronic diseases and assess patient statuses in the hospital, outpatient and physicians’ office settings. Beckman Coulter offers products such as consumables as well as instruments for the testing of allergies.
Minaris Medica America, Inc. (US)
Minaris Medical, formerly known as Hitachi Chemical Co. Ltd., held the third position in the allergy diagnostics market in 2020, with a share of 9.3%. The company is among the global companies offering Multiplex Allergy In Vitro Diagnostics. The OPTIGEN Allergen-Specific IgE Assay is a comprehensive panel test for environmental and food allergens. Minaris works with laboratories, industry leaders, and distributors worldwide to offer the medical community access to the latest in vitro allergy testing technology. Products manufactured by Minaris for allergy testing are currently marketed to over 20 countries across the globe.
Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, ELISA Analyzer, Luminometer), Service), Allergen (Food, Inhaled, Drug), Test Type (In Vivo, In Vitro), End User (Diagnostic Laboratories) - Global Forecast to 2026
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE